-The Telegraph New Delhi: Health activists campaigning for affordable treatment on Wednesday urged the Narendra Modi government to resist "pressure" from foreign medical device makers and expand price caps to new classes of medical devices. The All India Drug Action Network (AIDAN), a consortium of non-government activists' groups, said it was concerned that a body of foreign medical device manufacturers had petitioned the US government seeking suspension or withdrawal of certain trade...
More »SEARCH RESULT
Total Matching Records found : 26
India on radar as Trump aims for cheaper drugs?
-The Times of India and other agencies WASHINGTON: United States President Donald Trump has promised to bring the cost of prescription drugs in the country "way down" and let other countries pay more for these medicines. If effected, Trump's new policy on prescription drugs, dicussed with his cabinet at the White House on Monday, could have grave implications for India. The US has long had a grouse with India over its patent...
More »Why NPPA didn't wait for govt to make knee implants 'essential' -Rema Nagarajan
-The Times of India In a first for a medical device, the public interest provision in the Drug Price Control Order (DPCO) 2013 was used by the National Pharmaceutical Pricing Authority to cap the price of knee implants. The NPPA cited "exorbitant prices being charged from patients in a non-regulated market" and "a failed market system where asymmetry of information between patient and the doctor has resulted into unethical practices and...
More »Govt may cap knee implant prices -Aesha Datta
-The Hindu Business Line Industry likely to meet officials today New Delhi: Patients with debilitating knee problems, requiring joint replacement surgeries, would soon regain spring in their steps. The National Pharmaceutical Pricing Authority (NPPA), which capped the prices of coronary stents in February, may cap the prices of knee implants soon. According to a source in the know of the developments, the price of knee implants is likely to be capped with just...
More »Stent prices: Firms, doctors got away with looting -Rema Nagarajan
-The Times of India NEW DELHI: The Modi government's efforts to cap the price of cardiac stents exposed the nexus between stent companies and hospitals in looting the public by overcharging them. But no action has been taken against either companies or hospitals. None of them paid penalties or faced charges for colluding to cheat the public. Contrast this with the US government which has, over the years, fined the three biggest...
More »
